Thinkcyte 採用
WebThinkCyte, headquartered in Tokyo, Japan, is a biotechnology company which develops innovative life science research, diagnostics, and treatments using integrated multidisciplinary technologies, and was founded in 2016. The company focuses on the research and development of drug discovery, cell therapy, and diagnostic platforms using … Webシンクサイト株式会社. シンクサイト社は、光学・情報科学・バイオ工学などの先端技術を融合させることで、生命科学・ヘルスケアの発展と革新を目指すベンチャー企業。. 多 …
Thinkcyte 採用
Did you know?
WebMar 7, 2024 · Vice President, Intellectual Property & Legal Affairs at Thinkcyte . Eiji is Vice President of Intellectual Property and Legal Affairs at Thinkcyte. He brings to this role more than 20 years of experience in intellec tual property and research in the biopharmaceutical industry. Prior to joining ThinkCyte, Dr. Nara served as Global Head of IP BD ... WebThinkCyte’s mission is to provide scientists and biomedical professionals with a transformational single-cell technology that accelerates biological discoveries and enable …
WebAug 2, 2024 · Business Outlook. Pros. Start up company with innovative technology in cytemetory. Cons. Still in the phase of products development. Be the first to find this review helpful. Helpful. Share. Viewing 1 - 1 of 1 English Reviews. WebCBO at ThinkCyte. “The high-throughput ability to characterize and isolate cell populations based on their image information without the use of markers or stains is highly compatible with cell manufacturing automation and enables stable, affordable, large-scale, high-quality standardized cell manufacturing processes.”
WebOpen Positions. We have two locations – Redwood City, CA, and Tokyo, Japan. If you think you are a fit for our team but don’t see a position listed, please contact us . WebJul 1, 2024 · Hitachi and ThinkCyte announce collaboration to develop an AI-driven cell analysis and sorting system. TOKYO, July 1, 2024 /PRNewswire/ -- Hitachi, Ltd. (TSE: …
WebThinkCyte LinkedInのフォロワー数712人。Deeper insights, better treatments - a single cell at a time ThinkCyte’s mission is to provide scientists and biomedical professionals with a transformational single-cell technology that accelerates biological discoveries and enable the development of novel treatments and diagnostics through the integration of advanced …
WebMay 19, 2024 · May 19, 2024, 10:00 ET. TOKYO, May 19, 2024 /PRNewswire/ -- ThinkCyte, Inc., a company focusing on the development of novel cell therapy, drug discovery and diagnostic platforms, announced today ... fradis ajándékokWebJan 23, 2024 · ThinkCyte, a biotechnology company pioneering a novel artificial intelligence (AI)-based cell analysis, characterization, and isolation platform, announced today the appointments of Dr. Diether ... fradi vs kecskemétWebFeb 28, 2024 · ThinkCyte, founded in 2016 with offices in Tokyo, Japan and San Carlos, California is a biotechnology company that develops innovative scientific instruments based on integrated, multidisciplinary ... fradika névWebSee what employees say it's like to work at THINKCYTE. Salaries, reviews, and more - all posted by employees working at THINKCYTE. fradi-kisvárdaWebApr 10, 2024 · Drug Discovery /Functional Genomics. Pooled high content phenotypic screens of genes and drugs. Compatible with multiple libraries including CRISPR gRNAs, … fradi zöldWebFunding. ThinkCyte has raised a total of ¥5.1B in funding over 4 rounds. Their latest funding was raised on May 19, 2024 from a Series B round. ThinkCyte is funded by 11 investors. Sysmex Corporation and Sumitomo Mitsui Trust Investment are the most recent investors. fradi.hu női kézilabda forumWebPrior to ThinkCyte, he was a Sakigake Scholar at Japan Science and Technology Agency and an assistant professor at the University of Tokyo, Department of Chemistry. Currently he is an associate professor at U. Tokyo with specialization in networked biophotonics and microfluidics. Sadao holds a Ph.D. in engineering from UC Berkeley. fradibusz